NXTC - NextCure  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NXTC is currently covered by 1 analysts with an average price target of $15. This is a potential upside of $45.13 (742.7%) from yesterday's end of day stock price of $1.78.

NextCure 's activity chart (see below) currently has 14 price targets and 12 ratings on display. The stock rating distribution of NXTC is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 62.88% with an average time for these price targets to be met of 264.18 days.

Highest price target for NXTC is $15, Lowest price target is $15, average price target is $15.

Most recent stock forecast was given by from PIPER SANDLER on 15-Jul-2025. First documented stock forecast 03-Jun-2019.

Currently out of the existing stock ratings of NXTC, 1 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 03-Jun-2019

$15

$13.35 (809.09%)

11 months 24 days ago
(15-Jul-2025)

10/12 (83.33%)

$10.24 (215.13%)

439

Buy Since 08-Aug-2023

$36

1 years 8 days ago
(01-Jul-2025)

0/3 (0%)

$28.31 (368.14%)

Buy Since 05-Nov-2021

$4

$-5.99 (-59.96%)

$72

1 years 11 months 7 days ago
(02-Aug-2024)

1/4 (25%)

$-15.2 (-79.17%)

249

Buy Since 24-Mar-2020

3 years 8 months 5 days ago
(04-Nov-2022)

2/2 (100%)

$-43.04 (-72.90%)

518

Buy Since 23-Aug-2022

$15

$3.36 (28.87%)

$19

3 years 10 months 16 days ago
(23-Aug-2022)

3/3 (100%)

$-38.28 (-71.85%)

469

Show more analysts

Please expand the browser size to see the chart

What is NXTC (NextCure ) average time for price targets to be met?

On average it took 264.18 days on average for the stock forecasts to be realized with a an average price target met ratio 62.88

Which analyst has the current highest performing score on NXTC (NextCure ) with a proven track record?

ASTHIKA GOONEWARDENE

Which analyst has the most public recommendations on NXTC (NextCure )?

Asthika Goonewardene works at TRUIST and has 2 price targets and 5 ratings on NXTC

Which analyst is the currently most bullish on NXTC (NextCure )?

Robert Hazlett with highest potential upside - $313.99

Which analyst is the currently most reserved on NXTC (NextCure )?

Gil Blum with lowest potential downside - -$5.99

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?